Czechia· CZ-0290685
BOEY
A other muscle relaxants, peripherally acting agents product containing botulinum toxin (trenibotuline) type e, registered in Czechia by AbbVie Limited, Dublin.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
The record
At a glance
SÚKL (Czech Republic)- Active substance
- BOTULINUM TOXIN (TRENIBOTULINE) TYPE E
- Manufacturer
- AbbVie Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- M03AX
- ATC class
- Other muscle relaxants, peripherally acting agents
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Botulinum toxin (trenibotuline) type e in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d7ec0b3-67ba-4c67-9542-4363ee94a321 GET /v1/drugs/8d7ec0b3-67ba-4c67-9542-4363ee94a321?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ PLV SOL",
"source": "sukl",
"strength": "1400U",
"pack_size": "1",
"substance": "BOTULINUM TOXIN (TRENIBOTULINE) TYPE E",
"cz_kod_sukl": "0290685",
"product_type": "BT",
"substance_codes": "5251",
"registration_state": "R",
"registration_number": "EU/1/26/2044/001"
}See everything about botulinum toxin (trenibotuline) type e.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.